Your browser is no longer supported. Please, upgrade your browser.
Settings
MACK [NASD]
Merrimack Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.30 Insider Own0.42% Shs Outstand13.40M Perf Week0.65%
Market Cap84.80M Forward P/E- EPS next Y- Insider Trans203.92% Shs Float13.36M Perf Month-2.67%
Income-4.00M PEG- EPS next Q- Inst Own64.50% Short Float2.61% Perf Quarter-19.51%
Sales- P/S- EPS this Y85.80% Inst Trans0.03% Short Ratio13.53 Perf Half Y-18.12%
Book/sh1.18 P/B5.25 EPS next Y- ROA-22.10% Target Price4.00 Perf Year91.64%
Cash/sh- P/C- EPS next 5Y5.60% ROE-24.10% 52W Range3.16 - 9.45 Perf YTD-10.16%
Dividend- P/FCF- EPS past 5Y55.90% ROI- 52W High-34.50% Beta2.30
Dividend %- Quick Ratio23.80 Sales past 5Y- Gross Margin- 52W Low95.88% ATR0.21
Employees- Current Ratio23.80 Sales Q/Q- Oper. Margin- RSI (14)44.45 Volatility3.68% 3.22%
OptionableYes Debt/Eq0.00 EPS Q/Q-379.20% Profit Margin- Rel Volume0.39 Prev Close6.32
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume25.80K Price6.19
Recom3.50 SMA20-1.58% SMA50-2.34% SMA200-0.91% Volume10,022 Change-2.06%
Oct-07-16Downgrade JP Morgan Overweight → Neutral
May-27-16Initiated Robert W. Baird Neutral $8
Dec-23-15Reiterated Mizuho Buy $16 → $13
Oct-27-15Reiterated Oppenheimer Outperform $13 → $15
Apr-21-15Reiterated Mizuho Buy $13 → $16
Oct-10-14Resumed Oppenheimer Outperform $9 → $11
Jul-08-14Resumed Brean Capital Buy $16
Jun-20-14Reiterated Oppenheimer Outperform $10 → $8.50
Aug-09-13Reiterated Oppenheimer Outperform $12 → $10
Jun-25-13Initiated Mizuho Buy $12
May-08-12Initiated Oppenheimer Outperform $12
Jun-08-21 05:31AM  
Jun-07-21 02:10PM  
May-28-21 08:00AM  
Mar-10-21 06:00PM  
Dec-10-20 02:10AM  
Dec-03-20 07:46AM  
Nov-29-20 12:12PM  
Nov-05-20 08:20AM  
Aug-07-20 08:20AM  
Aug-05-20 08:33AM  
May-07-20 06:10PM  
Apr-02-20 08:30AM  
Feb-07-20 11:14AM  
Dec-22-19 07:44PM  
Dec-03-19 09:15AM  
08:45AM  
Oct-28-19 06:04AM  
Sep-24-19 04:45PM  
Sep-19-19 03:23PM  
09:00AM  
Aug-26-19 11:27AM  
09:00AM  
Aug-22-19 08:30AM  
Aug-16-19 09:15AM  
Jul-25-19 08:30AM  
May-31-19 07:34AM  
06:21AM  
May-30-19 04:05PM  
May-10-19 07:30AM  
May-06-19 01:46PM  
May-03-19 05:43PM  
Apr-18-19 03:07PM  
Apr-16-19 04:15PM  
Apr-12-19 01:57PM  
Apr-09-19 05:50PM  
Apr-08-19 10:12AM  
Apr-05-19 08:29AM  
07:48AM  
Apr-04-19 05:58PM  
04:15PM  
Mar-07-19 09:06AM  
Mar-06-19 07:00AM  
Feb-12-19 07:35AM  
Feb-11-19 09:39AM  
Jan-28-19 10:19PM  
Dec-10-18 05:00PM  
Nov-09-18 10:31AM  
08:45AM  
Nov-08-18 10:17AM  
Nov-07-18 06:45AM  
Nov-06-18 01:44PM  
Nov-05-18 07:55AM  
Oct-31-18 04:05PM  
Oct-24-18 11:19AM  
Oct-19-18 10:48AM  
07:46AM  
06:00AM  
Oct-16-18 07:30AM  
Oct-11-18 05:16PM  
Sep-20-18 07:00AM  
Sep-06-18 10:35AM  
06:50AM  
Sep-05-18 12:06PM  
Sep-04-18 10:07AM  
Aug-16-18 08:00AM  
Aug-08-18 10:20AM  
Aug-07-18 08:18AM  
06:30AM  
06:30AM  
Aug-01-18 12:09PM  
Jul-31-18 04:10PM  
Jul-10-18 04:55PM  
Jul-02-18 04:15PM  
Jun-27-18 08:12AM  
Jun-26-18 07:51PM  
08:12AM  
Jun-25-18 07:55AM  
07:54AM  
07:29AM  
07:20AM  
Jun-15-18 08:41AM  
Jun-07-18 09:15AM  
Jun-04-18 01:57PM  
May-29-18 08:15AM  
07:00AM  
May-09-18 10:49AM  
May-08-18 06:25AM  
May-03-18 10:13AM  
May-01-18 07:00AM  
Apr-09-18 07:30AM  
Apr-04-18 08:15AM  
Mar-14-18 07:30AM  
Mar-13-18 09:45AM  
Mar-12-18 07:06PM  
07:30AM  
06:27AM  
06:25AM  
Mar-05-18 07:00AM  
Feb-27-18 05:11AM  
Feb-26-18 06:55AM  
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andersen EricDirectorApr 14Buy6.6347,300313,736947,396Apr 16 04:05 PM
Andersen EricDirectorApr 13Buy6.269,87461,780906,591Apr 15 04:05 PM
Andersen EricDirectorApr 12Buy6.0623,629143,194896,717Apr 14 04:05 PM
CROCKER GARY LSee RemarksApr 12Buy6.079735,90533,731Apr 14 04:05 PM
CROCKER GARY LSee RemarksApr 09Buy6.101,2007,32032,758Apr 12 04:05 PM
CROCKER GARY LSee RemarksApr 07Buy6.192,12713,16631,558Apr 09 04:05 PM
CROCKER GARY LSee RemarksMar 25Buy6.132001,22628,931Mar 26 05:46 PM
CROCKER GARY LSee RemarksMar 24Buy6.345,00031,69028,731Mar 25 05:50 PM
CROCKER GARY LSee RemarksMar 23Buy6.473,62723,45523,731Mar 25 05:50 PM
CROCKER GARY LSee RemarksMar 16Buy6.795,00033,95620,104Mar 17 05:08 PM
CROCKER GARY LSee RemarksFeb 23Buy7.205,00036,00415,104Mar 05 04:05 PM
CROCKER GARY LSee RemarksFeb 12Buy7.475,00037,34210,104Feb 17 04:05 PM
CROCKER GARY LSee RemarksFeb 11Buy7.981,60412,7985,104Feb 12 06:16 PM
CROCKER GARY LSee RemarksFeb 10Buy7.643,50026,7573,500Feb 12 06:16 PM
Levy Noah G.DirectorDec 01Buy4.0029,776119,077896,642Dec 03 04:05 PM
Andersen EricDirectorNov 24Buy3.6569,088252,171873,088Nov 27 04:05 PM
Levy Noah G.DirectorNov 24Buy3.6569,087252,168879,283Nov 27 04:05 PM
Andersen EricDirectorNov 12Buy3.6556,490206,188822,014Nov 16 04:05 PM
Levy Noah G.DirectorNov 12Buy3.6556,490205,912839,005Nov 16 04:05 PM
Levy Noah G.DirectorAug 13Buy3.506082,128806,071Aug 17 04:05 PM
Andersen EricDirectorAug 13Buy3.506092,132820,055Aug 17 04:05 PM
Andersen EricDirectorAug 12Buy3.492,0006,986243,212Aug 13 04:06 PM
Levy Noah G.DirectorAug 12Buy3.492,0006,986805,717Aug 13 04:05 PM
Levy Noah G.DirectorAug 11Buy3.4514,04248,480804,551Aug 13 04:05 PM
Andersen EricDirectorAug 11Buy3.4514,03048,437241,212Aug 13 04:06 PM